Stayble Therapeutics AB
559024-8372ActiveDeveloping an injection treatment for pain caused by disc herniation.
Clinical Pharmaceutical Company / Biotechnology Firmstaybletherapeutics.com
Oversigt
- 5–9
- Medarbejdere
- 300–399t SEK
- Omsætning
- 2015
- Grundlagt
Nøglebeslutningstagere
Andreas Gerward
CEO
@stayble.se+46730XXXXXX
Anders Lehmann
Chief Scientific Officer
@stayble.se
Erik Kullgren
CFO
Gunnar Fernström
Board member
+4 flere kontakter i Funnelfeedr
Beskrivelse
Stayble Therapeutics is a clinical pharmaceutical company focused on developing innovative treatments for debilitating leg pain caused by Lumbar Disc Herniation (LDH). Their core product candidate, STA363, is a patented, disease-modifying treatment administered via a single injection. This therapy a...